2.3 Neuromuscular Physiology & Salivary Function
Key Takeaways
- At the neuromuscular junction, motor-nerve ACh binds nicotinic receptors on skeletal muscle, opening Na⁺ channels and triggering an end-plate potential that initiates the muscle action potential.
- Skeletal muscle is voluntary and multinucleated; cardiac muscle is striated with intercalated discs and intrinsic pacemaker activity; smooth muscle is non-striated and autonomic—each type appears in orofacial structures.
- Saliva is ~99% water with electrolytes, mucins, amylase, lingual lipase, lysozyme, lactoferrin, IgA, and buffering bicarbonate critical for enamel protection and bolus formation.
- Unstimulated flow is largely submandibular; stimulated flow is parotid-dominant; parasympathetic (CN VII/IX) drives watery secretion and sympathetic tone modulates protein-rich composition.
- Xerostomia causes include medications (anticholinergics, antihistamines, antidepressants, antihypertensives), Sjögren disease, head-and-neck radiation, uncontrolled diabetes, and dehydration—major caries and candidiasis risk factors.
2.3 Neuromuscular Physiology & Salivary Function
Quick Answer: Skeletal muscle contracts when acetylcholine (ACh) from the motor neuron binds nicotinic receptors at the neuromuscular junction (NMJ), depolarizing the end plate and triggering a muscle action potential and Ca²⁺-dependent cross-bridge cycling. Saliva—mostly water plus buffers, mucins, enzymes, and IgA—protects teeth and mucosa; parasympathetic input drives watery flow. Xerostomia from drugs, Sjögren disease, radiation, or systemic disease sharply raises caries and candidiasis risk.
This section closes the physiology chapter by linking nerve–muscle transmission (mastication, facial expression, tongue, and the targets of local anesthesia) with salivary gland function (caries prevention, taste, swallowing, and oral medicine).
The Neuromuscular Junction
Sequence of transmission
- Motor neuron action potential invades the presynaptic terminal
- Voltage-gated Ca²⁺ channels open; Ca²⁺ enters the terminal
- Synaptic vesicles release ACh into the synaptic cleft
- ACh binds nicotinic ACh receptors on the motor end plate (ligand-gated cation channels)
- Na⁺ influx produces an end-plate potential (EPP)
- If threshold is reached, a muscle action potential propagates along the sarcolemma and into T-tubules
- Dihydropyridine receptors couple to ryanodine receptors on sarcoplasmic reticulum → Ca²⁺ release
- Ca²⁺ binds troponin C, moves tropomyosin, allows actin–myosin cross-bridges → contraction
- ACh is rapidly hydrolyzed by acetylcholinesterase in the cleft; Ca²⁺ is pumped back into SR → relaxation
High-yield NMJ pharmacology physiology (AFK overlap)
| Agent / condition | Mechanism at NMJ | Result |
|---|---|---|
| Botulinum toxin | Blocks presynaptic ACh release | Flaccid paralysis of injected muscles |
| Curare-like nondepolarizing blockers | Competitive nicotinic antagonists | Paralysis (anesthesia context) |
| Succinylcholine | Depolarizing agonist then persistent depolarization block | Transient fasciculations then paralysis |
| Acetylcholinesterase inhibitors | ↑ ACh in cleft | Stronger/longer end-plate stimulation (myasthenia treatment; toxicity → SLUDGE/cholinergic crisis) |
| Myasthenia gravis | Autoantibodies to nicotinic AChR (classic) | Fatigable weakness; oropharyngeal involvement possible |
| Local anesthetics | Block voltage-gated Na⁺ channels on axons | Prevent action potential propagation (not primarily NMJ ACh release) |
Remember the distinction: local anesthetics stop axonal conduction; they do not act as the primary NMJ ACh-receptor story. Botulinum toxin and myasthenia do live at the NMJ.
Excitation–contraction coupling essentials
- ATP is required both for cross-bridge cycling and for SR Ca²⁺-ATPase (relaxation)
- Rigor patterns appear when ATP is depleted (conceptual physiology; postmortem rigor is the extreme teaching example)
- Motor units: one motor neuron + all muscle fibers it innervates; fine control (extraocular, some facial/tongue units) uses small motor units; force recruitment adds larger units
Muscle Types Relevant to Dentistry
| Feature | Skeletal | Cardiac | Smooth |
|---|---|---|---|
| Control | Somatic (voluntary) | Autonomic + intrinsic pacemaker | Autonomic / hormonal |
| Histology | Striated, multinucleated, long fibers | Striated, branched, intercalated discs (gap junctions) | Non-striated, spindle cells |
| NMJ | Classic motor end plates | No discrete skeletal-type NMJ; autonomic varicosities + conducting system | Diffuse autonomic innervation |
| Ca²⁺ source | Mainly SR | SR + extracellular Ca²⁺ | Extracellular Ca²⁺ prominent |
| Orofacial examples | Masseter, temporalis, tongue, facial expression muscles | Myocardium (systemic) | Vascular walls, gut, some glandular myoepithelium-related control contexts |
Masticatory muscle physiology notes
- Masseter, temporalis, medial pterygoid — elevators; lateral pterygoid — protrusion/depression contributions (anatomy chapter details attachments)
- Masticatory muscles are skeletal but exhibit specialized fiber-type mixes for force and endurance; bruxism is prolonged isometric-like activity that can cause pain and hypertrophy
- Stretch reflexes and periodontal mechanoreceptors help regulate bite force—protective unloading when a hard object is bitten unexpectedly
- TMJ loading is neuromuscular: muscle hyperactivity + joint anatomy interact (pain chapters expand clinical TMDs)
Autonomic contrast for glands and vessels
While skeletal muscle uses nicotinic NMJs, autonomic postganglionic endings use:
- Parasympathetic: mainly ACh on muscarinic receptors (glands, smooth muscle)
- Sympathetic: mainly norepinephrine on adrenergic receptors (vascular tone; glandular protein secretion modulation)
This receptor split explains why anticholinergic drugs dry the mouth (block muscarinic salivation) without paralyzing masseter the way a nicotinic NMJ blocker would.
Salivary Gland Physiology
Major glands and ducts (functional view)
| Gland | Approx. contribution (stimulated vs resting teaching pattern) | Secretion character | Duct opening |
|---|---|---|---|
| Parotid | Dominant under stimulation (~60%+ of stimulated flow) | Serous, amylase-rich | Stensen duct (buccal opposite maxillary molars) |
| Submandibular | Dominant unstimulated (~60–70% resting) | Mixed seromucous | Wharton duct (floor of mouth) |
| Sublingual | Smaller continuous mucinous contribution | Mainly mucous | Multiple ducts of Rivinus / Bartholin |
| Minor glands | Continuous mucosal coating | Mucous-rich; von Ebner serous in taste areas | Throughout mucosa |
Whole saliva is not just glandular fluid—it includes crevicular fluid, microbes, desquamated cells, and food debris. Glandular saliva is the protective core.
Composition
Saliva is approximately 99% water. Key solutes and macromolecules:
| Component | Function |
|---|---|
| Water | Lubrication, solvent for taste, bolus formation |
| Bicarbonate and phosphates | Buffer plaque acids; protect enamel |
| Mucins (e.g., MUC5B, MUC7) | Viscoelastic coat; antimicrobial binding; lubrication |
| α-Amylase | Starch digestion; binds some oral bacteria |
| Lingual lipase | Minor lipid digestion begins in mouth |
| Lysozyme, lactoferrin, peroxidase | Innate antimicrobial systems |
| sIgA | Adaptive mucosal immunity |
| Calcium and phosphate ions | Supersaturation supporting remineralization of enamel |
| Statherin, proline-rich proteins | Stabilize Ca/PO₄; pellicle formation |
| Epidermal growth factors / histatins | Soft-tissue homeostasis; antifungal (histatins) |
pH and buffering: resting saliva is often near neutral to slightly acidic; stimulated saliva is more bicarbonate-rich and better buffered—another reason chewing and gustatory stimulation protect teeth after acid challenges.
Control of secretion
- Parasympathetic (primary volume driver):
- Parotid: CN IX (glossopharyngeal) via otic ganglion → auriculotemporal
- Submandibular/sublingual: CN VII (facial) via chorda tympani → submandibular ganglion
- Muscarinic receptors → watery, electrolyte-rich flow; vasodilation of glandular vessels
- Sympathetic: superior cervical ganglion fibers; tends to favor protein-rich, lower-volume secretion and modulates composition; also influences blood flow
- Stimuli: taste (especially acid), mastication, smell, higher centers (appetite); conditioned responses exist
- Inhibition: fear/dehydration/sleep lower flow; anticholinergic drugs block muscarinic drive
Primary vs secondary saliva: acini produce isotonic primary secretion; ducts reabsorb Na⁺/Cl⁻ and secrete K⁺/HCO₃⁻, yielding a normally hypotonic final saliva at low flow rates. At high flow rates, ductal modification time falls—composition approaches primary fluid (higher Na⁺).
Normal flow rates (order-of-magnitude teaching values)
| Condition | Typical whole-saliva order of magnitude |
|---|---|
| Unstimulated | ~0.3–0.4 mL/min (hyposalivation often cited if unstimulated ≤0.1 mL/min) |
| Stimulated | ~1–2+ mL/min (hyposalivation often if stimulated ≤0.5–0.7 mL/min—know concept thresholds) |
Exact cutoffs vary by source; AFK cares that you know unstimulated vs stimulated, which gland dominates each, and that low flow = disease risk.
Xerostomia and Hyposalivation
Xerostomia is the symptom of dry mouth; hyposalivation is objectively reduced flow. They overlap but are not identical—some patients feel dry with normal measured flow and vice versa.
Major causes
- Medications (most common in general practice populations)
- Anticholinergics, antimuscarinics
- First-generation antihistamines
- Tricyclic and many other antidepressants
- Antipsychotics
- Antihypertensives (e.g., some diuretics, clonidine, others)
- Opioids, polypharmacy in elderly
- Head-and-neck radiotherapy — irreversible acinar damage when glands in field; severe, persistent hyposalivation
- Sjögren disease — autoimmune destruction of exocrine glands; dry mouth + dry eyes; caries, candidiasis, parotid enlargement patterns
- Uncontrolled diabetes mellitus — dehydration and altered fluid balance
- Dehydration, mouth breathing, smoking, aging-related polypharmacy (aging alone is a weaker primary cause than drugs)
- Chemotherapy, HIV, graft-versus-host disease, sarcoidosis, glandular obstruction/infection (sialolithiasis more often painful swelling than pure xerostomia)
Consequences dentists manage daily
- Rampant cervical and root caries
- Oral candidiasis, burning mouth complaints
- Dysgeusia, difficulty chewing/swallowing/speaking
- Denture instability and mucosal trauma
- Ascending sialadenitis risk when flow is very low
Management principles (physiology-based)
- Stimulate residual parenchyma: sugar-free gum/lozenges, gustatory sialogogues
- Pharmacologic sialogogues (pilocarpine, cevimeline) when residual tissue exists and systemic status allows—muscarinic agonists
- Topical saliva substitutes, high-fluoride regimens, dietary sugar control, antifungal therapy as needed
- Review drug list with physician when xerostomia is medication-driven
- Radiation patients: lifelong aggressive caries prevention; recognize irreversible acinar loss
Putting NMJ and Saliva Together for AFK
Expect integrated stems such as:
- A patient on multiple anticholinergic drugs develops new root caries → link muscarinic blockade → hyposalivation → loss of buffer/remineralizing ions
- Botulinum toxin for masseter hypertrophy → presynaptic ACh release block → reduced bite force
- Sjögren disease → lymphocytic gland destruction → low unstimulated flow (submandibular-dominant resting secretion lost) → candidiasis
- Local anesthetic failure vs true NMJ disease → Na⁺ channel block on nerve vs AChR problem at muscle
Rapid review list
- NMJ sequence: AP → Ca²⁺ in → ACh out → nicotinic EPP → muscle AP → SR Ca²⁺ → troponin → contraction
- AChE ends the signal; botulinum stops release; myasthenia attacks receptors
- Skeletal vs cardiac vs smooth table from memory
- Parotid = serous, IX; submandibular = mixed, VII; resting vs stimulated dominance
- Saliva buffers, remineralizes, lubricates, and provides innate/adaptive antimicrobials
- Xerostomia causes: drugs, Sjögren, radiation, diabetes, dehydration
Master this triad—NMJ, muscle type, saliva—and you can answer pure physiology items and the oral-medicine stems that depend on them.
At the skeletal neuromuscular junction, acetylcholine binds which receptor class on the motor end plate?
Which major salivary gland contributes the largest share of unstimulated (resting) whole saliva?
Botulinum toxin reduces muscle activity primarily by which mechanism?
Which set most accurately lists common causes of hyposalivation/xerostomia relevant to dental practice?